Why these 4 ASX shares are climbing higher today

The Bellamy's Australia Ltd (ASX:BAL) share price is one of four climbing higher today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has continued its strong run and is up a further 0.8% to 5,892 points in early afternoon trade.

Four shares which have made notably stronger gains today are listed below. Here's why they have surged higher:

The Bellamy's Australia Ltd (ASX: BAL) share price is up almost 4% to $11.42 despite there being no news out of the organic baby food and formula company. Bellamy's shares have now risen over 30% since last week's full-year profit upgrade announcement. I feel that its shares are looking a touch overvalued now.

The Challenger Ltd (ASX: CGF) share price is up 5% to $13.14 after the investment management company provided a quarterly update. According to the release, Challenger's total group assets under management was $73.5 billion as of the end of September 2017, up 5% on the previous quarter.

The Mobecom Ltd (ASX: MBM) share price has had a strong start to life on the ASX and is up 37.5% to 27.5 cents. The marketing tech start-up raised $5 million at 20 cents per share from the listing and will use the funds to roll out its digital currency solution, airBux, in 2018. Management believes the airBux platform puts Mobecom in a position to leverage the growth of cryptocurrency markets and blockchain technologies in the coming years.

The Sigma Healthcare Ltd (ASX: SIG) share price has climbed 5% to 87.2 cents following the release of a positive update on its dispute with My Chemist/Chemist Warehouse Group (MC/CW). According to the release, MC/CW has agreed not to procure certain products from a different supplier until the end of its current agreement. While it is a positive development, there's no guarantee that MC/CW will stick around when the agreement expires in 2019.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »